Alida Biosciences today announced the launch of its EpiPlex™ Tri-Mod™ Service, enabling simultaneous detection and quantification of three key mRNA modifications—N6-methyladenosine (m6A), inosine, and ...
A research paper by scientists at University of Oxford presented a humanoid robotic bioreactor capable of delivering ...
The development of tendon tissue engineering and regenerative medicine depends heavily on whether in vitro mechanical stimulation can faithfully ...
Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...
Researchers analyzing 761 first-trimester pregnancies found that SARS-CoV-2 was rarely detected in placental tissues, ...
Researchers from The University of Texas MD Anderson Cancer Center will present breakthrough studies at the American Association for Cancer Research (AACR) Annual Meeting 2026.
Qlucore, listed on Nasdaq First North, announces the launch of a new Qlucore Insights test (Research Use Only) specifically developed for Acute Myeloid Leukemia (AML). The software-based test delivers ...
The advent of immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized oncology. However, a significant proportion of patients ...
Cancer metabolism has re-emerged as a central hallmark of tumor initiation, progression, and therapeutic resistance. Advances in high-throughput ...
Tempus AI TEM shares are up on Tuesday as the company announced the acceptance of 31 abstracts for presentation at the ...
BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health ...
DNADX high scores predicted improved PFS, supporting genomic instability and DNA repair deficiency as biologically relevant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results